These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 12169040)

  • 21. Pharmacokinetic properties of fentanyl effervescent buccal tablets: a phase I, open-label, crossover study of single-dose 100, 200, 400, and 800 microg in healthy adult volunteers.
    Darwish M; Kirby M; Robertson P; Tracewell W; Jiang JG
    Clin Ther; 2006 May; 28(5):707-14. PubMed ID: 16861092
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A comparison of ebastine 10 mg fast-dissolving tablet with oral desloratadine and placebo in inhibiting the cutaneous reaction to histamine in healthy adults.
    Antonijoan RM; García-Gea C; Puntes M; Valle M; Esbri R; Fortea J; Barbanoj MJ
    Clin Drug Investig; 2007; 27(7):453-61. PubMed ID: 17563125
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A phase I, randomized, open-label, crossover study of the single-dose pharmacokinetic properties of guanfacine extended-release 1-, 2-, and 4-mg tablets in healthy adults.
    Swearingen D; Pennick M; Shojaei A; Lyne A; Fiske K
    Clin Ther; 2007 Apr; 29(4):617-25. PubMed ID: 17617285
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Circadian time-effect of orally administered loratadine on plasma pharmacokinetics in mice.
    Dridi D; Ben-Attia M; Sani M; Djebli N; Sauvage FL; Boughattas NA
    Chronobiol Int; 2008 Jul; 25(4):533-47. PubMed ID: 18622814
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacokinetics of desloratadine in children between 2 and 11 years of age.
    Gupta S; Khalilieh S; Kantesaria B; Banfield C
    Br J Clin Pharmacol; 2007 May; 63(5):534-40. PubMed ID: 17488362
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetic properties of mirabegron, a β3-adrenoceptor agonist: results from two phase I, randomized, multiple-dose studies in healthy young and elderly men and women.
    Krauwinkel W; van Dijk J; Schaddelee M; Eltink C; Meijer J; Strabach G; van Marle S; Kerbusch V; van Gelderen M
    Clin Ther; 2012 Oct; 34(10):2144-60. PubMed ID: 23063375
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A retrospective, open-label analysis of the population pharmacokinetics of a single 10-mg dose of loratadine in healthy white Jordanian male volunteers.
    Salem II; Najib NM; Idkaidek NM
    Clin Ther; 2010 Feb; 32(2):391-5. PubMed ID: 20206796
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dose proportionality and the effects of food on bioavailability of an immediate-release oxycodone hydrochloride tablet designed to discourage tampering and its relative bioavailability compared with a marketed oxycodone tablet under fed conditions: a single-dose, randomized, open-label, 5-way crossover study in healthy volunteers.
    Bass A; Stark JG; Pixton GC; Sommerville KW; Zamora CA; Leibowitz M; Rolleri R
    Clin Ther; 2012 Jul; 34(7):1601-12. PubMed ID: 22717418
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dose proportionality and pharmacokinetics of fentanyl buccal soluble film in healthy subjects: a phase I, open-label, three-period, crossover study.
    Finn AL; Vasisht N; Stark JG; Gever LN; Tagarro I
    Clin Drug Investig; 2012 Jan; 32(1):63-71. PubMed ID: 22128878
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A pharmacokinetic comparison of single doses of once-daily cyclobenzaprine extended-release 15 mg and 30 mg: a randomized, double-blind, two-period crossover study in healthy volunteers.
    Darwish M; Chang S; Hellriegel ET
    Clin Ther; 2009 Jan; 31(1):108-14. PubMed ID: 19243711
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The pharmacologic profile of desloratadine: a review.
    Henz BM
    Allergy; 2001; 56 Suppl 65():7-13. PubMed ID: 11243504
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Linagliptin, a dipeptidyl peptidase-4 inhibitor in development for the treatment of type 2 diabetes mellitus: a Phase I, randomized, double-blind, placebo-controlled trial of single and multiple escalating doses in healthy adult male Japanese subjects.
    Sarashina A; Sesoko S; Nakashima M; Hayashi N; Taniguchi A; Horie Y; Graefe-Mody EU; Woerle HJ; Dugi KA
    Clin Ther; 2010 Jun; 32(6):1188-204. PubMed ID: 20637971
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A single-dose, three-period, six-sequence crossover study comparing the bioavailability of solution, suspension, and enteric-coated tablets of magnesium valproate in healthy Mexican volunteers under fasting conditions.
    Marcelín-Jiménez G; Angeles-Moreno AP; Contreras-Zavala L; Morales-Martínez M; Rivera-Espinosa L
    Clin Ther; 2009 Sep; 31(9):2002-11. PubMed ID: 19843490
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A randomised, two-period, cross-over, open-label study to evaluate the pharmacokinetic profiles of single doses of two different flurbiprofen 8.75-mg lozenges in healthy volunteers.
    Matzneller P; Burian A; Martin W; Annoni O; Lauro V; Tacchi R; Brunner M; Zeitlinger M
    Pharmacology; 2012; 89(3-4):188-91. PubMed ID: 22433300
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetic-pharmacodynamic interaction between nebicapone and controlled-release levodopa/benserazide: a single-center, Phase I, double-blind, randomized, placebo-controlled, four-way crossover study in healthy subjects.
    Nunes T; Machado R; Rocha JF; Fernandes-Lopes C; Costa R; Torrão L; Loureiro AI; Falcão A; Vaz-da-Silva M; Wright L; Almeida L; Soares-da-Silva P
    Clin Ther; 2009 Oct; 31(10):2258-71. PubMed ID: 19922897
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The pharmacokinetics and bioavailability of clemastine and phenylpropanolamine in single-component and combination formulations.
    Schran HF; Petryk L; Chang CT; O'Connor R; Gelbert MB
    J Clin Pharmacol; 1996 Oct; 36(10):911-22. PubMed ID: 8930778
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Desloratadine dose selection in children aged 6 months to 2 years: comparison of population pharmacokinetics between children and adults.
    Gupta SK; Kantesaria B; Banfield C; Wang Z
    Br J Clin Pharmacol; 2007 Aug; 64(2):174-84. PubMed ID: 17324243
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence of desloratadine poor metabolizer phenotype in healthy Jordanian males.
    Hakooz N; Salem II
    Biopharm Drug Dispos; 2012 Jan; 33(1):15-21. PubMed ID: 22271705
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetics/pharmacodynamics of desloratadine and fluoxetine in healthy volunteers.
    Gupta S; Banfield C; Kantesaria B; Flannery B; Herron J
    J Clin Pharmacol; 2004 Nov; 44(11):1252-9. PubMed ID: 15496643
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetics of duloxetine hydrochloride enteric-coated tablets in healthy Chinese volunteers: a randomized, open-label, single- and multiple-dose study.
    Zhao RK; Cheng G; Tang J; Song J; Peng WX
    Clin Ther; 2009 May; 31(5):1022-36. PubMed ID: 19539103
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.